2Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 2009,27 : 6550-6557.
3卫生部.全国人群乙型病毒性肝炎血清流行病学调查报告.北京:人民卫生出版社,2011:1-70.
4Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003,38 Suppl: S 1042-1048.
5Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis, 2001,33 (8) : 572-580.
6Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C infection. Lancet Infect Dis, 2005,5 : 558-567.
7Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008, 48: 148-162.
8Mele A, Tosti ME, Marzolini A, et al. Prevemion of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA Collaborating Group. J Viral Hepat, 2000, 7 : 30-35.
9Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis, 2005, 37: 622-628.
10Fabris P, Baldo V, Baldovin T, et al. Changing epidemiology of HCV and HBV infections in Northern Italy. A survey in the general population. J Clin Gastroenterol, 2008,42: 527-532.
8Thomas DL,Seeff LB. Natural history of hepatitis C[J]. Clin Liver Dis, 2005,9 (3) : 383- 398.
9Ayyub MA, EI-Moursy SA, Khazindar AM, et al. Successful treatment of chronic hepatitis C virus infection with peginter- feron alpha-2a and ribavirin in patients with sickle cell disease [J]. Saudi Med J,2009,30(5) :712-716.
10Lavanchy D. The global burden of hepatitis C[J]. Liver Int,2009,29(Suppl 1):74-81.
